Four patients in Denmark, who experienced vision loss after using Novo Nordisk's popular weight-loss and diabetes drugs ...
The past three or four years, the L has not been a pleasant experience, and it’s a dangerous experience, at worst,” one ...
Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...
Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...
Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...
BOZEMAN, MT – November 04, 2025 – PRESSADVANTAGE – Glaucoma continues to be one of the most significant causes of vision loss across the country, often developing slowly and without obvious warning ...
Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred. Known as the “silent thief of sight,” the disease ...
Discover a study linking allergic rhinitis to a higher risk of optic neuritis, revealing shared inflammatory pathways and key clinical insights.
Scientists at Wake Forest University School of Medicine, in collaboration with researchers at Weill Cornell Medicine, have made a breakthrough in understanding why many cancer patients develop nerve ...
Purpose: This study aimed to evaluate abnormalities in the retinal nerve fiber layer and ganglion cell layer in patients with thyroid-associated orbitopathy using optical coherence tomography and to ...
Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...
If you or a loved one experienced sudden vision loss, blindness, or optic nerve damage after using Ozempic or Wegovy, you may have a legal claim against the drug manufacturers. Parker Waichman LLP is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results